Event

9th Annual Microbiome Movement Summit

Date : January 24, 2025

Sharing our positive Phase 3 results evaluating MaaT013 in treating acute Graft-versus-Host Disease with gastrointestinal involvement

For more information, visit: https://microbiome-europe.com/

January 21, 2025: MaaT Pharma Announces Positive Second DSMB Review of Ongoing Phase 2b Clinical Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT

17th « Journée GREFFE» of the IPC